Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18160303

Download in:

View as

General Info

PMID
18160303